Testing a blood-membrane target to treat leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study looks for a specific marker on leukemia cells and uses it to guide treatment. If you qualify, your care team will check whether this target can be detected and used to help treat your leukemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer (a leukemia or other blood malignancy).
- You are at least 18 years old.
- You must be able to understand and make decisions about study participation.
- You must be able to speak and understand English.
- You cannot be pregnant (or have a pregnancy involving a fetus) during the study.
- You cannot be incarcerated (in prison) to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to check how blood cancers respond to immunotherapy. It looks at small blood or bone marrow samples before and during treatment to help doctors choose the best therapy.
This trial is set up to review tumor lab test results to help doctors choose the most appropriate next treatment for people with leukemia that has returned or did not respond. It mainly matters for younger patients who are not already on a standard treatment path.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This study collects blood samples over time from adults with certain blood cancers to better understand why treatments stop working. It may help researchers improve how future therapies are chosen for patients whose disease becomes resistant.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study uses advanced tests (genetics and other 'omics' methods) to better understand your leukemia and find a treatment that targets its specific features. It may help if standard treatments haven't worked or stopped working.
Hear when a new Hematological Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.